KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueDividends payablesLand & ImprovementsLiabilities and Shareholders EquityLoans - NetMinority InterestOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Accounts Payables (2016 - 2025)

Historic Accounts Payables for National Health Investors (NHI) over the last 17 years, with Q3 2025 value amounting to $34.7 million.

  • National Health Investors' Accounts Payables rose 660.15% to $34.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.7 million, marking a year-over-year increase of 660.15%. This contributed to the annual value of $37.8 million for FY2024, which is 1006.59% up from last year.
  • Latest data reveals that National Health Investors reported Accounts Payables of $34.7 million as of Q3 2025, which was up 660.15% from $33.0 million recorded in Q2 2025.
  • Over the past 5 years, National Health Investors' Accounts Payables peaked at $37.8 million during Q4 2024, and registered a low of $19.1 million during Q1 2022.
  • Moreover, its 5-year median value for Accounts Payables was $26.8 million (2024), whereas its average is $28.0 million.
  • Per our database at Business Quant, National Health Investors' Accounts Payables crashed by 3502.36% in 2021 and then surged by 3242.23% in 2023.
  • National Health Investors' Accounts Payables (Quarter) stood at $23.2 million in 2021, then rose by 11.75% to $25.9 million in 2022, then skyrocketed by 32.42% to $34.3 million in 2023, then increased by 10.07% to $37.8 million in 2024, then decreased by 8.22% to $34.7 million in 2025.
  • Its Accounts Payables was $34.7 million in Q3 2025, compared to $33.0 million in Q2 2025 and $29.2 million in Q1 2025.